Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
The use of biologics is rapidly increasing as new drugs are approved for label expansions. Monoclonal antibodies, multispecific antibodies, and antibody-drug conjugates (ADCs) are being implemented in an array of fields, including oncology, immunology, and neurology. As clinical demand for biologics increases, biopharmaceutical companies must ensure that they have the manufacturing capacity available to produce enough biologics.
Let’s face it, though there have been improvements throughout the years, when it comes to healthcare, our system still isn’t equitable. From a dearth of research on female-specific diseases to the dominance of male participants in clinical trials, much remains to be done to create equitable health outcomes. There are differences between male and female anatomy that can lead to differences in health and disease risk.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
